slotkoers
Korea S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4.800
KRW
|
-0,10%
|
|
-1,84%
|
-15,79%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
118.505
|
137.624
|
142.830
|
117.712
|
100.392
|
87.364
|
Bedrijfswaarde
1 |
115.561
|
125.219
|
133.016
|
101.565
|
99.285
|
102.864
|
K/w-verhouding
|
59,3
x
|
8,48
x
|
11,1
x
|
23,5
x
|
12,3
x
|
54,8
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,24
x
|
1,19
x
|
1,14
x
|
0,84
x
|
0,6
x
|
0,47
x
|
Bedrijfswaarde/omzet
|
1,21
x
|
1,08
x
|
1,07
x
|
0,72
x
|
0,59
x
|
0,55
x
|
Bedrijfswaarde/EBITDA
|
13,4
x
|
8,79
x
|
10,5
x
|
13,7
x
|
7,65
x
|
13,1
x
|
Bedrijfswaarde/FCF
|
-5,35
x
|
18,3
x
|
-17,4
x
|
38,4
x
|
-5,93
x
|
-5,18
x
|
FCF Yield
|
-18,7%
|
5,47%
|
-5,74%
|
2,61%
|
-16,9%
|
-19,3%
|
Price to Book
|
1,91
x
|
1,9
x
|
1,71
x
|
1,42
x
|
1,11
x
|
0,96
x
|
Aantal aandelen (in duizenden)
|
15.113
|
15.373
|
15.469
|
15.327
|
15.327
|
15.327
|
Referentieprijs
2 |
7.841
|
8.952
|
9.233
|
7.680
|
6.550
|
5.700
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
95.338
|
115.793
|
124.809
|
140.157
|
167.737
|
187.155
|
EBITDA
1 |
8.595
|
14.251
|
12.629
|
7.400
|
12.977
|
7.844
|
Bedrijfsresultaat (EBIT)
1 |
7.367
|
12.538
|
10.599
|
4.794
|
9.864
|
3.073
|
Operationele Marge
|
7,73%
|
10,83%
|
8,49%
|
3,42%
|
5,88%
|
1,64%
|
Resultaat voor belastingen (EBT)
1 |
2.078
|
12.151
|
9.728
|
5.605
|
8.391
|
3.476
|
Nettowinst (verlies)
1 |
1.218
|
10.031
|
8.372
|
4.930
|
8.034
|
3.061
|
Nettomarge
|
1,28%
|
8,66%
|
6,71%
|
3,52%
|
4,79%
|
1,64%
|
WPA
2 |
132,2
|
1.055
|
831,0
|
326,9
|
532,0
|
104,0
|
Free Cash Flow
1 |
-21.618
|
6.847
|
-7.641
|
2.647
|
-16.738
|
-19.870
|
FCF-marge
|
-22,68%
|
5,91%
|
-6,12%
|
1,89%
|
-9,98%
|
-10,62%
|
Kasstroomconversie (ebitda)
|
-
|
48,05%
|
-
|
35,76%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
68,26%
|
-
|
53,69%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
15.499
|
Nettokaspositie
1 |
2.944
|
12.405
|
9.814
|
16.146
|
1.107
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
1,976
x
|
Free Cash Flow
1 |
-21.618
|
6.847
|
-7.641
|
2.647
|
-16.738
|
-19.870
|
ROE (netto-inkomsten/eigen vermogen)
|
2,99%
|
15,1%
|
11,2%
|
6,21%
|
9,47%
|
3,45%
|
ROA (netto-inkomsten/totale activa)
|
5,47%
|
6,83%
|
5,78%
|
2,59%
|
4,49%
|
1,17%
|
Totale activa
1 |
22.258
|
146.776
|
144.730
|
190.320
|
178.933
|
260.637
|
Nettoactief per aandeel
2 |
4.106
|
4.723
|
5.400
|
5.404
|
5.898
|
5.933
|
Cashflow per aandeel
2 |
155,0
|
798,0
|
383,0
|
634,0
|
1.558
|
1.270
|
Capex
1 |
17.454
|
2.646
|
9.389
|
5.268
|
18.974
|
23.385
|
Capex/omzet
|
18,31%
|
2,28%
|
7,52%
|
3,76%
|
11,31%
|
12,49%
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -15,79% | 53,39 mln. | | +20,04% | 43,77 mld. | | +30,16% | 22,83 mld. | | +21,21% | 15,56 mld. | | +18,29% | 14,34 mld. | | +54,61% | 12,96 mld. | | -0,05% | 6,79 mld. | | -11,72% | 6,41 mld. | | -8,87% | 5,73 mld. | | +14,65% | 5,69 mld. |
Generieke geneesmiddelen
|